Crescent Capital BDC Inc. (CCAP) Financial Statements (2025 and earlier)
Company Profile
Business Address |
11100 SANTA MONICA BLVD. LOS ANGELES, CA 90025 |
State of Incorp. | MD |
Fiscal Year End | December 31 |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | |||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash, cash equivalents, and short-term investments | 7,780 | 6,397 | |||
Cash and cash equivalents | 7,780 | 6,397 | |||
Total current assets: | 7,780 | 6,397 | |||
Noncurrent Assets | |||||
Deferred income tax assets | 114 | 91 | |||
Total noncurrent assets: | 114 | 91 | |||
Other undisclosed assets | 1,619,485 | 1,296,390 | |||
TOTAL ASSETS: | 1,627,379 | 1,302,878 | |||
LIABILITIES AND EQUITY | |||||
Liabilities | |||||
Current Liabilities | |||||
Noncurrent Liabilities | |||||
Liabilities, other than long-term debt | 578 | 899 | |||
Deferred income tax liabilities | 578 | 899 | |||
Total noncurrent liabilities: | 578 | 899 | |||
Other undisclosed liabilities | 884,207 | 689,438 | |||
Total liabilities: | 884,785 | 690,337 | |||
Equity | |||||
Equity, attributable to parent | 742,594 | 612,541 | |||
Common stock | 37 | 31 | |||
Additional paid in capital | 965,895 | 675,008 | |||
Accumulated deficit | (223,338) | (62,498) | |||
Total equity: | 742,594 | 612,541 | |||
TOTAL LIABILITIES AND EQUITY: | 1,627,379 | 1,302,878 |
Income Statement (P&L) ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2022 | ||
---|---|---|---|---|
Revenues | ||||
Net investment income | ||||
Cost of revenue (Cost of Goods and Services Sold) | (1,276) | (481) | ||
Gross profit: | (1,276) | (481) | ||
Operating expenses | ||||
Other undisclosed operating loss | (99,010) | (56,352) | ||
Operating loss: | (100,286) | (56,833) | ||
Nonoperating income (expense) | 116,717 | |||
Investment income, nonoperating | 116,717 | |||
Loss, foreign currency transaction, before tax | ||||
Interest and debt expense | (58,742) | (31,880) | ||
Income (loss) from continuing operations before equity method investments, income taxes: | (159,028) | 28,004 | ||
Other undisclosed income from continuing operations before income taxes | 242,876 | 31,880 | ||
Income from continuing operations before income taxes: | 83,848 | 59,884 | ||
Income tax expense (benefit) | (31) | 326 | ||
Other undisclosed loss from continuing operations | ||||
Net income: | 83,817 | 60,210 | ||
Other undisclosed net income (loss) attributable to parent | 20 | (44,666) | ||
Net income available to common stockholders, diluted: | 83,837 | 15,544 |
Comprehensive Income ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2022 | ||
---|---|---|---|---|
Net income: | 83,817 | 60,210 | ||
Comprehensive income, net of tax, attributable to parent: | 83,817 | 60,210 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.